Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sudhir. R. Iliger"'
Publikováno v:
Research Journal of Pharmaceutical Dosage Forms and Technology. :100-106
Repaglinide is an anti-diabetic, oral blood-glucose lowering drug of the meglitinide class used in the management of type-II diabetes mellitus. The present investigation was concerned with the development of the floating matrix tablets, which after o
Autor:
R. A. Shastry R. A. Shastry, Sudhir R. Iliger, V. H. Kulkarni, Prasanna Vasantarao Habbu, D. M. Smita
Publikováno v:
JOURNAL OF NATURAL REMEDIES. 20:29-41
In the present investigation, we have carried out the isolation of fungal endophytes from Centella asiatica Linn leaves followed by fermentation and extraction of fungal endophytes with non-polar solvents such as chloroform, ethyl acetate and n-butan
Publikováno v:
Archives of Gynecology and Obstetrics. 297:161-183
Breast cancer is a severe risk to public health and has adequately convoluted pathogenesis. Therefore, the description of key molecular markers and pathways is of much importance for clarifying the molecular mechanism of breast cancer-associated fibr
Autor:
Bhautik V. Patel, Ajeet Madhukar Godbole, Shalin P. Thakker, Sandesh Narayan Somnache, Sudhir R. Iliger, Ashwini S. Joshi
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 48:7-17
The formulation of sublingual tablets of Ondansetron HCl was carried out by using direct compression technique and evaluation tests were carried out as per pharmacopoeial specifications. Poor compressibility problem of Mannitol was overcome by coproc
Autor:
Uttam A. More, Sudhir R. Iliger, V. H. Kulkarni, Ajit P. Rokhade, Shalin P. Thakker, Tejraj M. Aminabhavi, Shivayya S. Abbigerimath
Publikováno v:
Polymer Bulletin. 71:2113-2131
Inter-polymer complexes (IPCs) of chitosan (CS) and cellulose acetate phthalate (CAP) have been prepared to develop spherical microspheres by a novel emulsion-solvent evaporation technique. The microspheres were used for the oral delivery of 5-fluoro
Publikováno v:
Indian Journal of Pharmaceutical Sciences. 69:402
Gelatin A microspheres of propranolol hydrochloride for intranasal systemic delivery were developed with the aim to avoid first pass metabolism, to improve the patient compliance, to use an alternative therapy to conventional dosage form, to achieve